Biggest News Aggregation in the World
📰 Patrick Harrison Carroll News

Patrick Harrison Carroll News Today

Fast, Ad-Free News Updates

Stay updated with breaking news from Patrick Harrison Carroll. Real-time updates on events, politics, business and more.

Hims & Hers Health (NYSE:HIMS) Shares Gap Down Following Insider Selling

Hims & Hers Health, Inc. (NYSE:HIMS – Get Free Report)’s share price gapped down before the market opened on Wednesday following insider selling activity. The stock had previously closed at $17.56, but opened at $17.11. Hims & Hers Health shares last traded at $16.71, with a volume of 1,528,158 shares traded. Specifically, insider Soleil Boughton […]
United Kingdom United States Soleil Boughton Patrick Harrison Carroll Piper Sandler York Mellon Corp

Zacks: Analysts Anticipate Hims & Hers Health, Inc. (NYSE:HIMS) to Post -$0.09 Earnings Per Share

Wall Street brokerages expect that Hims & Hers Health, Inc. (NYSE:HIMS – Get Rating) will announce earnings per share of ($0.09) for the current quarter, Zacks reports. Three analysts have issued estimates for Hims & Hers Health’s earnings, with the highest EPS estimate coming in at ($0.06) and the lowest estimate coming in at ($0.13). […]
Lynne Chou Okeefe Patrick Harrison Carroll Piper Sandler Chiron Capital Management Hims Hers Health Get Rating Russell Investments Group Ltd

Hims & Hers Health, Inc. (NYSE:HIMS) Given Consensus Rating of "Hold" by Brokerages

Shares of Hims & Hers Health, Inc. (NYSE:HIMS – Get Rating) have received a consensus recommendation of “Hold” from the nine ratings firms that are covering the firm, Marketbeat Ratings reports. One analyst has rated the stock with a sell rating, three have assigned a hold rating and four have assigned a buy rating to […]
Lynne Chou Okeefe Patrick Harrison Carroll Piper Sandler Securities Exchange Commission Zacks Investment Research Deutsche Bank Aktiengesellschaft

Hims & Hers Health (NYSE:HIMS) Cut to "Strong Sell" at Zacks Investment Research

Hims & Hers Health (NYSE:HIMS – Get Rating) was downgraded by Zacks Investment Research from a “hold” rating to a “strong sell” rating in a report issued on Tuesday, Zacks.com reports. According to Zacks, “Hims & Hers Health Inc. is a multi-specialty telehealth platform that connects consumers to licensed healthcare professionals, enabling medical care for […]
San Francisco United States Patrick Harrison Carroll Soleil Boughton Piper Sandler Chiron Capital Management

Stay Updated with Latest News

Get breaking news updates delivered to your inbox

Browse All News →

Hims & Hers Health, Inc. (NYSE:HIMS) Expected to Post Quarterly Sales of $90.10 Million

Analysts forecast that Hims & Hers Health, Inc. (NYSE:HIMS – Get Rating) will report $90.10 million in sales for the current fiscal quarter, according to Zacks. Two analysts have issued estimates for Hims & Hers Health’s earnings. The highest sales estimate is $92.45 million and the lowest is $87.74 million. Hims & Hers Health posted […]
Thomson Reuter Patrick Harrison Carroll Soleil Boughton Piper Sandler Zacks Investment Research Deutsche Bank Aktiengesellschaft

Hims & Hers Health, Inc. (NYSE:HIMS) Expected to Post Earnings of -$0.10 Per Share

Brokerages forecast that Hims & Hers Health, Inc. (NYSE:HIMS – Get Rating) will announce ($0.10) earnings per share (EPS) for the current fiscal quarter, Zacks reports. Two analysts have issued estimates for Hims & Hers Health’s earnings, with estimates ranging from ($0.13) to ($0.06). Hims & Hers Health posted earnings per share of ($0.14) in […]
United States Patrick Harrison Carroll Soleil Boughton Piper Sandler Hims Hers Health Get Rating Hightower Advisors

Zacks: Analysts Anticipate Hims & Hers Health, Inc. (NYSE:HIMS) Will Post Quarterly Sales of $90.10 Million

Analysts forecast that Hims & Hers Health, Inc. (NYSE:HIMS – Get Rating) will announce $90.10 million in sales for the current quarter, according to Zacks. Two analysts have issued estimates for Hims & Hers Health’s earnings, with estimates ranging from $87.74 million to $92.45 million. Hims & Hers Health reported sales of $52.31 million in […]
Lynne Chou Okeefe Patrick Harrison Carroll Piper Sandler Zacks Investment Research Deutsche Bank Aktiengesellschaft Hims Hers Health

Patrick Harrison Carroll Sells 86,820 Shares of Hims & Hers Health, Inc. (NYSE:HIMS) Stock

Hims & Hers Health, Inc. (NYSE:HIMS – Get Rating) Director Patrick Harrison Carroll sold 86,820 shares of the company’s stock in a transaction dated Monday, February 28th. The shares were sold at an average price of $5.17, for a total transaction of $448,859.40. The transaction was disclosed in a document filed with the SEC, which […]
Patrick Harrison Carroll Piper Sandler Hims Hers Health Get Rating Morgan Stanley Zacks Investment Research Blackrock Inc

Explore More Categories

World News India News Business Technology Sports Entertainment Health Science